article thumbnail

CVS and Walgreens Walkouts: What Independent Pharmacies Should Know

Digital Pharmacist

By understanding what led retail pharmacy team members to take these drastic actions, we can look at what independent pharmacies can do to avoid similar issues and also how independents can help members of these communities affected by the closures of retail chains.

article thumbnail

Comparing Mark Cuban Cost Plus Drug Company (MCCPDC) and Independent Pharmacies

Digital Pharmacist

MCCPDC is able to offer low pricing because they “cut out the pharmacy middlemen and negotiate directly with manufacturers” In this blog, we will explore the differences between independent pharmacies and Mark Cuban Cost Plus Drug Company and how MCCPDC could potentially affect independent pharmacies. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Top Clinical Services for Boosting Your Pharmacy’s Revenue

Digital Pharmacist

With reimbursements dwindling and the so-called “ DIR Apocalypse ” or “DIR Armageddon” on the horizon, no explanation is needed as to why independent pharmacies are seeking innovative ways to expand their revenue streams beyond traditional prescription dispensing.

article thumbnail

The Lilly Digest

Ramblings of a pharmacist

The NCPA Digest reports that the GDR for independent pharmacies was only 86% for 2020.” ” Including compounds with brands will understate the GDR, with generics will overstate the GDR, and excluding compounds will deflate the volume of the pharmacy, increasing the calculated cost of dispensing.

article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

Key Medicare tools to safeguard against pharmacy fraud and inappropriate billing do not apply to Part D. NHC comments to the FTC on PBM business practices and the impact on independent pharmacies and consumers. Prior authorization and association with delayed or discontinued prescription fills. Blendon, R.,

article thumbnail

January 2025 Newsletter

Safe Biologics

Small molecule drugs make up over 90% of prescriptions filled in the U.S. Additionally, PBM-affiliated pharmacies were reimbursed at significantly higher rates than independent pharmacies, further disadvantaging unaffiliated competitors.The report also noted that plan sponsors paid $4.8 Read the FTC Report here.